Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

AbbVie Inc (ABBV)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
164.66 +0.41    +0.25%
18/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
164.43
-0.23
-0.14%
9:26:10 - Real-time Data
  • Volume: 4,479,202
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 164.43 - 167.44
Type:  Equity
Market:  United States
AbbVie 164.66 +0.41 +0.25%

ABBV Balance Sheet

 
Assess the latest AbbVie balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced ABBV Annual Report data, financial summaries and charts are available for AbbVie Inc investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 33002 33224 28852 26488
Cash and Short Term Investments 12816 13290 6722 6722
Cash - - - -
Cash & Equivalents 12814 13287 8759 6711
Short Term Investments 2 3 7 11
Total Receivables, Net 11155 11412 11491 11473
Accounts Receivables - Trade, Net 11155 11412 11491 11473
Total Inventory 4099 3981 4055 3833
Prepaid Expenses 4866 4389 4452 4348
Other Current Assets, Total 66 152 88 112
Total Assets 134711 136221 135367 134544
Property/Plant/Equipment, Total - Net 5733 4934 4943 4931
Property/Plant/Equipment, Total - Gross 12379 11374 11318 11142
Accumulated Depreciation, Total -6646 -6440 -6375 -6211
Goodwill, Net 32293 32091 32224 32220
Intangibles, Net 55610 58603 62862 64848
Long Term Investments 304 275 288 268
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 7769 7094 6198 5789
Other Assets, Total -6988 -7276 -7341 -7517
Total Current Liabilities 37841 34773 32239 27590
Accounts Payable 3688 29262 26610 24361
Payable/Accrued - - - -
Accrued Expenses 15789 - - -
Notes Payable/Short Term Debt - 2 - 1
Current Port. of LT Debt/Capital Leases 7357 5115 5204 2817
Other Current liabilities, Total 11007 394 425 411
Total Liabilities 124314 124092 122469 121241
Total Long Term Debt 52487 56065 56189 59643
Long Term Debt 52460 56065 56189 59643
Capital Lease Obligations 27 - - -
Deferred Income Tax 1952 2044 2124 2110
Minority Interest 37 35 32 29
Other Liabilities, Total 29997 29173 29885 29868
Total Equity 10397 12129 13303 13303
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 18 18 18 18
Additional Paid-In Capital 20180 20021 19839 19619
Retained Earnings (Accumulated Deficit) -1000 933 1789 2393
Treasury Stock - Common -6533 -6525 -6528 -6524
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -2268 -2318 -2220 -2203
Total Liabilities & Shareholders' Equity 134711 136221 135367 134544
Total Common Shares Outstanding 1765.94 1765.49 1764.8 1763.97
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ABBV Price Commentary

Write your thoughts about AbbVie Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alan Ng
Alan Ng Oct 07, 2021 15:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Abbv going up again.
Reply
3 0
Report
tyler dong
tyler dong Sep 01, 2021 16:36
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What is happening to abbvie?
Reply
0 0
Report
Matous B
Matous B Sep 01, 2021 16:36
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ABBV : FDA requires updated warnings on JAK inhibitors citing increased risks of heart events10:56 am, Wed, Sep. 1, 2021
Reply
2 0
Report
Oc Masai
Oc Masai Jul 12, 2021 18:33
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bullish guys
Reply
0 0
Report
Thusara Dissanayake
Thusara Dissanayake Jan 30, 2016 18:06
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hi how will be EUR/USD next week
Reply
0 8
Report
James Macdonald
James Macdonald Jan 30, 2016 18:06
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cloudy with a chance of rain
Reply
2 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email